Insiders · Profile

Kelsey Stephen Michael

See Remarks at Revolution Medicines · EVP, R&D Head, CMO at GERON. Filing since 28 Apr 2010. CIK 0001462808

Company
Date
Role
Action
Shares
Amount
Of holding
16 Sep 2026
See Remarks
Sold on a plan
5,569
$1.11M
1.9%
11 Sep 2026
See Remarks
Sold on a plan
92,531
$18.72M
24.1%
16 Jun 2026
See Remarks
Sold on a plan
4,175
$651.80K
1.4%
17 Mar 2026
See Remarks
Sold on a plan
4,302
$427.96K
1.4%
16 Dec 2025
See Remarks
Sold on a plan
5,447
$418.42K
1.9%
13 Oct 2025
See Remarks
Sold on a plan
25,000
$1.21M
8.1%
16 Sep 2025
See Remarks
Sold on a plan
5,367
$245.94K
1.9%
15 Sep 2025
See Remarks
Sold on a plan
25,000
$1.15M
8.0%
11 Sep 2025
See Remarks
Sold on a plan
100,000
$4.41M
25.7%
16 Jun 2025
See Remarks
Sold on a plan
4,289
$170.83K
1.5%
17 Mar 2025
See Remarks
Sold on a plan
3,294
$128.60K
1.1%
16 Dec 2024
See Remarks
Sold on a plan
4,663
$211.72K
1.8%
13 Nov 2024
See Remarks
Sold on a plan
16,666
$977.51K
5.9%
14 Oct 2024
See Remarks
Sold on a plan
16,666
$824.80K
5.9%
16 Sep 2024
See Remarks
Sold on a plan
4,665
$206.12K
1.7%
13 Sep 2024
See Remarks
Sold on a plan
16,667
$722.09K
5.8%
13 Aug 2024
See Remarks
Sold on a plan
16,667
$716.39K
5.8%
15 Jul 2024
See Remarks
Sold on a plan
16,667
$774.52K
5.8%
25 Jun 2024
See Remarks
Sold on a plan
16,467
$643.15K
5.8%
24 Jun 2024
See Remarks
Sold on a plan
200
$7.80K
0.1%
17 Jun 2024
See Remarks
Sold on a plan
3,349
$125.21K
1.2%
18 Mar 2024
See Remarks
Sold on a plan
2,123
$67.05K
0.8%
8 Jan 2024
See Remarks
Sold on a plan
3,337
$96.81K
1.5%
2 Jan 2024
See Remarks
Sold on a plan
13,330
$387.88K
5.6%
27 Dec 2023
See Remarks
Sold on a plan
33,334
$967.00K
12.3%
18 Dec 2023
See Remarks
Sold on a plan
2,088
$54.08K
0.8%
11 Oct 2023
See Remarks
Sold on a plan
16,667
$484.13K
5.7%
18 Sep 2023
See Remarks
Sold at will
2,060
$64.50K
0.7%
2 Aug 2023
See Remarks
Sold on a plan
16,666
$539.98K
5.4%
1 Aug 2023
See Remarks
Sold on a plan
16,666
$486.50K
5.1%
20 Jun 2023
See Remarks
Sold at will
2,102
$52.32K
0.6%
17 Mar 2023
See Remarks
Sold at will
1,230
$26.79K
0.4%
19 Dec 2022
See Remarks
Sold, plan not stated
1,220
$27.99K
0.4%
19 Sep 2022
See Remarks
Sold, plan not stated
1,267
$24.13K
0.4%
17 Jun 2022
See Remarks
Sold, plan not stated
1,145
$20.32K
0.4%
17 Mar 2022
See Remarks
Sold, plan not stated
321
$5.98K
0.1%
17 Dec 2021
See Remarks
Sold, plan not stated
343
$8.37K
0.1%
17 Sep 2021
See Remarks
Sold, plan not stated
335
$10.06K
0.1%
17 Jun 2021
See Remarks
Sold, plan not stated
324
$11.06K
0.1%
30 Sep 2020
See Remarks
Sold, plan not stated
17,248
$592.06K
6.8%
29 Sep 2020
See Remarks
Sold, plan not stated
13,268
$452.91K
5.3%
28 Sep 2020
See Remarks
Sold, plan not stated
9,384
$319.83K
3.8%
23 Sep 2020
See Remarks
Sold, plan not stated
100
$3.40K
0.0%
22 Sep 2020
See Remarks
Sold, plan not stated
98
$3.23K
0.0%
21 Sep 2020
See Remarks
Sold, plan not stated
14,902
$491.80K
5.9%
18 Sep 2020
See Remarks
Sold, plan not stated
637
$19.77K
0.3%
17 Sep 2020
See Remarks
Sold, plan not stated
11,363
$352.56K
4.3%
10 Sep 2020
See Remarks
Sold, plan not stated
2,542
$73.88K
1.0%
9 Sep 2020
See Remarks
Sold, plan not stated
100
$2.90K
0.0%
8 Sep 2020
See Remarks
Sold, plan not stated
1,400
$40.68K
0.5%
3 Sep 2020
See Remarks
Sold, plan not stated
1,400
$40.70K
0.5%
2 Sep 2020
See Remarks
Sold, plan not stated
826
$23.97K
0.3%
1 Sep 2020
See Remarks
Sold, plan not stated
10,000
$276.72K
3.6%
28 Aug 2020
See Remarks
Sold, plan not stated
118
$3.42K
0.0%
27 Aug 2020
See Remarks
Sold, plan not stated
1,614
$46.83K
0.6%
13 Aug 2020
See Remarks
Sold, plan not stated
4,900
$135.00K
1.8%
12 Aug 2020
See Remarks
Sold, plan not stated
10,100
$261.69K
3.6%
30 May 2012
EVP, R&D Head, CMO
Sold, plan not stated
9,300
$12.74K
1.9%
14 Jun 2011
EVP, R&D Head, CMO
Sold, plan not stated
4,858
$20.79K
1.0%
5 May 2011
EVP, CMO, Oncology
Sold, plan not stated
14,163
$68.41K
3.7%
28 Apr 2010
EVP, CMO, Oncology
Sold, plan not stated
3,707
$20.98K
9.3%
61 decisions on file.